Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin

Abstract Streptomyces rapamycinicus NRRL 5491 is a well-known producer of rapamycin, a secondary metabolite with useful bioactivities, including antifungal, antitumor, and immunosuppressive functions. For the enhanced rapamycin production, a rapamycin-overproducing strain SRMK07 was previously obtai...

Full description

Bibliographic Details
Main Authors: Hee-Geun Jo, Joshua Julio Adidjaja, Do-Kyung Kim, Bu-Soo Park, Namil Lee, Byung-Kwan Cho, Hyun Uk Kim, Min-Kyu Oh
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-14199-6
_version_ 1811343683552804864
author Hee-Geun Jo
Joshua Julio Adidjaja
Do-Kyung Kim
Bu-Soo Park
Namil Lee
Byung-Kwan Cho
Hyun Uk Kim
Min-Kyu Oh
author_facet Hee-Geun Jo
Joshua Julio Adidjaja
Do-Kyung Kim
Bu-Soo Park
Namil Lee
Byung-Kwan Cho
Hyun Uk Kim
Min-Kyu Oh
author_sort Hee-Geun Jo
collection DOAJ
description Abstract Streptomyces rapamycinicus NRRL 5491 is a well-known producer of rapamycin, a secondary metabolite with useful bioactivities, including antifungal, antitumor, and immunosuppressive functions. For the enhanced rapamycin production, a rapamycin-overproducing strain SRMK07 was previously obtained as a result of random mutagenesis. To identify genomic changes that allowed the SRMK07 strain’s enhanced rapamycin production, genomes of the NRRL 5491 and SRMK07 strains were newly sequenced in this study. The resulting genome sequences of the wild-type and SRMK07 strains showed the size of 12.47 Mbp and 9.56 Mbp, respectively. Large deletions were observed at both end regions of the SRMK07 strain’s genome, which cover 17 biosynthetic gene clusters (BGCs) encoding secondary metabolites. Also, genes in a genomic region containing the rapamycin BGC were shown to be duplicated. Finally, comparative metabolic network analysis using these two strains’ genome-scale metabolic models revealed biochemical reactions with different metabolic fluxes, which were all associated with NADPH generation. Taken together, the genomic and computational approaches undertaken in this study suggest biological clues for the enhanced rapamycin production of the SRMK07 strain. These clues can also serve as a basis for systematic engineering of a production host for further enhanced rapamycin production.
first_indexed 2024-04-13T19:33:08Z
format Article
id doaj.art-37a14f6883f64b1481b4d67393a2df1a
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T19:33:08Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-37a14f6883f64b1481b4d67393a2df1a2022-12-22T02:33:07ZengNature PortfolioScientific Reports2045-23222022-06-0112111310.1038/s41598-022-14199-6Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycinHee-Geun Jo0Joshua Julio Adidjaja1Do-Kyung Kim2Bu-Soo Park3Namil Lee4Byung-Kwan Cho5Hyun Uk Kim6Min-Kyu Oh7Department of Chemical and Biological Engineering, Korea UniversityDepartment of Chemical and Biomolecular Engineering (BK21 Four), Korea Advanced Institute of Science and Technology (KAIST)Department of Chemical and Biological Engineering, Korea UniversityDepartment of Chemical and Biological Engineering, Korea UniversityDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST)Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST)Department of Chemical and Biomolecular Engineering (BK21 Four), Korea Advanced Institute of Science and Technology (KAIST)Department of Chemical and Biological Engineering, Korea UniversityAbstract Streptomyces rapamycinicus NRRL 5491 is a well-known producer of rapamycin, a secondary metabolite with useful bioactivities, including antifungal, antitumor, and immunosuppressive functions. For the enhanced rapamycin production, a rapamycin-overproducing strain SRMK07 was previously obtained as a result of random mutagenesis. To identify genomic changes that allowed the SRMK07 strain’s enhanced rapamycin production, genomes of the NRRL 5491 and SRMK07 strains were newly sequenced in this study. The resulting genome sequences of the wild-type and SRMK07 strains showed the size of 12.47 Mbp and 9.56 Mbp, respectively. Large deletions were observed at both end regions of the SRMK07 strain’s genome, which cover 17 biosynthetic gene clusters (BGCs) encoding secondary metabolites. Also, genes in a genomic region containing the rapamycin BGC were shown to be duplicated. Finally, comparative metabolic network analysis using these two strains’ genome-scale metabolic models revealed biochemical reactions with different metabolic fluxes, which were all associated with NADPH generation. Taken together, the genomic and computational approaches undertaken in this study suggest biological clues for the enhanced rapamycin production of the SRMK07 strain. These clues can also serve as a basis for systematic engineering of a production host for further enhanced rapamycin production.https://doi.org/10.1038/s41598-022-14199-6
spellingShingle Hee-Geun Jo
Joshua Julio Adidjaja
Do-Kyung Kim
Bu-Soo Park
Namil Lee
Byung-Kwan Cho
Hyun Uk Kim
Min-Kyu Oh
Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
Scientific Reports
title Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
title_full Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
title_fullStr Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
title_full_unstemmed Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
title_short Comparative genomic analysis of Streptomyces rapamycinicus NRRL 5491 and its mutant overproducing rapamycin
title_sort comparative genomic analysis of streptomyces rapamycinicus nrrl 5491 and its mutant overproducing rapamycin
url https://doi.org/10.1038/s41598-022-14199-6
work_keys_str_mv AT heegeunjo comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT joshuajulioadidjaja comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT dokyungkim comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT busoopark comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT namillee comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT byungkwancho comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT hyunukkim comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin
AT minkyuoh comparativegenomicanalysisofstreptomycesrapamycinicusnrrl5491anditsmutantoverproducingrapamycin